Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (33)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simmons, M. S.
Right arrow Articles by Tashkin, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simmons, M. S.
Right arrow Articles by Tashkin, D. P.
(Chest. 2000;118:290-295.)
© 2000 American College of Chest Physicians

Unpredictability of Deception in Compliance With Physician-Prescribed Bronchodilator Inhaler Use in a Clinical Trial*

Michael S. Simmons; Mitchell A. Nides, PhD; Cynthia S. Rand, PhD; Robert A. Wise, MD, FCCP and Donald P. Tashkin, MD, FCCP

* From the UCLA School of Medicine (Mr. Simmons and Drs. Nides and Tashkin), Los Angeles, CA; and Johns Hopkins University School of Medicine (Drs. Rand and Wise), Baltimore, MD.

Correspondence to: Michael Simmons, Department of Medicine, Division of Pulmonary and Critical Care Medicine, UCLA, Los Angeles, CA 90095-1690; e-mail: msimm{at}ucla.edu

Objective: To identify subject characteristics that may be predictive of intentional dumping of metered-dose inhalers (MDIs) during a clinical trial.

Design: Nebulizer Chronologs (NCs; Medtrac Technologies; Lakewood, CO), which record the date and time of each MDI actuation, were attached to the MDIs of participants who were given a prescribed medication schedule to follow in a clinical trial. Participants were not informed of the function of the NC or that their medication use was being monitored.

Setting: The Lung Health Study, a 5-year clinical trial to evaluate the effect of intensive smoking cessation counseling and regular use of an inhaled bronchodilator on the progression of COPD.

Participants: One hundred one smokers, 35 to 60 years of age, with mild to moderate airways obstruction enrolled in The Lung Health Study.

Measurements and results: Thirty of these 101 participants (30%) actuated their inhalers > 100 times within a 3-h interval on at least one occasion during the first year of this 5-year trial. Only 1 of an additional 135 participants who had full foreknowledge of the MDI monitoring capability of the NC did so. Most of these dumping episodes occurred shortly before a clinic follow-up visit, suggesting an active attempt to hide noncompliance from the clinic staff. Whereas self-reported inhaler usage and canister weights were similar for the "dumpers" and "nondumpers," NC data indicated significantly lower compliance rates for dumpers ({chi}2; p < 0.05). When demographic variables, treatment and clinic assignments, smoking status, pulmonary function test results, respiratory symptoms, and disease history of dumpers and nondumpers were analyzed, no predictors of dumping could be found.

Conclusions: Deception among noncompliers occurs frequently in clinical trials, is often not revealed by the usual methods of monitoring, and cannot be predicted by data readily available in clinical trials.

Key Words: COPD • electronic monitoring devices • metered-dose inhalers • patient compliance




This article has been cited by other articles:


Home page
Chronic Respiratory DiseaseHome page
D L Cullen
Long term oxygen therapy adherence and COPD: what we don't know
Chronic Respiratory Disease, November 1, 2006; 3(4): 217 - 222.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
D. Wendler and F. G. Miller
Deception in the Pursuit of Science
Arch Intern Med, March 22, 2004; 164(6): 597 - 600.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. A. Clowes, N. F. A. Peel, and R. Eastell
The Impact of Monitoring on Adherence and Persistence with Antiresorptive Treatment for Postmenopausal Osteoporosis: A Randomized Controlled Trial
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1117 - 1123.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. K. Nakanishi, A. K. Klasner, and B. K. Rubin
A Randomized Controlled Trial of Inhaled Flunisolide in the Management of Acute Asthma in Children
Chest, September 1, 2003; 124(3): 790 - 794.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
R. R. Bies, M. R. Gastonguay, K. C. Coley, P. D. Kroboth, and B. G. Pollock
Evaluating the Consistency of Pharmacotherapy Exposure by Use of State-of-the-Art Techniques
Am J Geriatr Psychiatry, December 1, 2002; 10(6): 696 - 705.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. Koller, S. Malozowski, S. Johnson, M. S. Simmons, and D. P. Tashkin
Deception in Bronchodilator Inhaler Use
Chest, April 1, 2001; 119(4): 1291 - 1292.
[Full Text] [PDF]


Home page
ChestHome page
S. Malozowski, E. Koller, M. S. Simmons, and D. P. Tashkin
Compliance With Bronchodilator Treatment
Chest, March 1, 2001; 119(3): 988 - 989.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American College of Chest Physicians.